InvestorsKeyhole Upgrades & Downgrades

Bristol-Myers upgraded to outperform

Analysts at BMO Capital Markets upgraded Bristol-Myers Squibb Company (BMY) to “outperform”. The firm has a $60 price target on the stock.

Already a member?

Login to see your Upgrades And Downgrades Trade Idea.

Not yet a member?

You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.

Become A Member

BMY
About Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs.

  • Last Price:
    $52.58
  • Previous Close:
    $53.08
  • Change:
    $-0.50 (-0.94%)
  • Open:
    $53.25
  • Volume:
    8,019,628
  • Average Volume (100 Day):
    7,453,021
  • Market Capitalization:
    $85.8 B
  • Day's Range:
    $51.37 - $53.29
  • Dividend Yield:
    3.09%
  • 52-week Range:
    $70 - $46.94
  • P-E:
    59.60
  • EPS:
    $0.89
  • Earnings Date:
    1/24/19
  • Ex Dividend Date:
    1/3/19
  • Sector:
    Healthcare
  • Industry:
    Drug Manufacturers - Major
  • Analyst Average Recommendation:
    Moderate Buy

Download this step-by-step guide on placing InvestorsKeyhole Daily Trade Alerts.

How to place a credit spread

How to place a vertical debit spread

|

You May Also Like